The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups
- PMID: 7575685
- DOI: 10.1002/art.1780381002
The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups
Abstract
Objective: To provide an indication of the economic, social, and psychological impact of musculoskeletal conditions in the United States.
Methods: Review of the literature combined with estimates of data concerning health care utilization and acute and chronic disability due to musculoskeletal conditions, from the 1990-1992 National Health Interview Survey.
Results: The cost of musculoskeletal conditions was $149.4 billion in 1992, of which 48% was due to direct medical care costs and the remainder was due to indirect costs resulting from wage losses. This amount translates to approximately 2.5% of the Gross National Product, a sharp rise since the prior studies, even if part of the increase is an artifact of improved accounting methods. Each year, persons with musculoskeletal conditions make 315 million physician visits, have more than 8 million hospital admissions, and experience approximately 1.5 billion days of restricted activity. Approximately 42% of persons with musculoskeletal conditions--more than 17 million in all--are limited in their activities.
Conclusion: The economic and social costs of musculoskeletal conditions are substantial. These conditions are responsible for a sizable amount of health care use and disability, and they significantly affect the psychological status of the individuals with the conditions as well as their families.
Comment in
-
The economic cost and social and psychological impact of musculoskeletal conditions: comment on the article by Yelin et al.Arthritis Rheum. 1996 Nov;39(11):1931. doi: 10.1002/art.1780391124. Arthritis Rheum. 1996. PMID: 8912518 No abstract available.
Similar articles
-
A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.Arthritis Rheum. 2001 May;44(5):1160-9. doi: 10.1002/1529-0131(200105)44:5<1160::AID-ANR199>3.0.CO;2-Y. Arthritis Rheum. 2001. PMID: 11352250
-
Cost of musculoskeletal diseases: impact of work disability and functional decline.J Rheumatol Suppl. 2003 Dec;68:8-11. J Rheumatol Suppl. 2003. PMID: 14712615 Review.
-
The economic cost and social and psychological impact of musculoskeletal conditions: comment on the article by Yelin et al.Arthritis Rheum. 1996 Nov;39(11):1931. doi: 10.1002/art.1780391124. Arthritis Rheum. 1996. PMID: 8912518 No abstract available.
-
The economic burden of musculoskeletal disease in Korea: a cross sectional study.BMC Musculoskelet Disord. 2011 Jul 13;12:157. doi: 10.1186/1471-2474-12-157. BMC Musculoskelet Disord. 2011. PMID: 21749727 Free PMC article.
-
The economic impact of the rheumatic diseases in the United States.J Rheumatol. 1989 Jul;16(7):867-84. J Rheumatol. 1989. PMID: 2527991 Review.
Cited by
-
Nanoindentation modulus of murine cartilage: a sensitive indicator of the initiation and progression of post-traumatic osteoarthritis.Osteoarthritis Cartilage. 2017 Jan;25(1):108-117. doi: 10.1016/j.joca.2016.08.008. Epub 2016 Aug 25. Osteoarthritis Cartilage. 2017. PMID: 27568574 Free PMC article.
-
Combination therapy for autoimmune diseases: the rheumatoid arthritis model.Springer Semin Immunopathol. 2001;23(1-2):5-26. doi: 10.1007/s002810100063. Springer Semin Immunopathol. 2001. PMID: 11455861 Review. No abstract available.
-
Potent anti-inflammatory and antiproliferative effects of gambogic acid in a rat model of antigen-induced arthritis.Mediators Inflamm. 2014;2014:195327. doi: 10.1155/2014/195327. Epub 2014 Jan 30. Mediators Inflamm. 2014. PMID: 24623960 Free PMC article.
-
Topographical variations in zonal properties of canine tibial articular cartilage due to early osteoarthritis: a study using 7-T magnetic resonance imaging at microscopic resolution.MAGMA. 2016 Aug;29(4):681-90. doi: 10.1007/s10334-016-0528-5. Epub 2016 Feb 17. MAGMA. 2016. PMID: 26886872 Free PMC article.
-
Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study.BMC Musculoskelet Disord. 2004 Oct 14;5(1):36. doi: 10.1186/1471-2474-5-36. BMC Musculoskelet Disord. 2004. PMID: 15485582 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical